Biweekly cetuximab in combination with capecitabine and oxaliplatin (XELOX) or irinotecan (XELIRI) in the first-line and second-line treatment of patients with RAS wild-type metast...

por Zekri, Jamal, Baghdadi, Mohammed Abbas, Ibrahim, Refaei Belal, Meliti, Abdelrazak, Sobahy, Turki M
Publicado 2022